CIK: 0001668343 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $81,483 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Rocket Lab USA, Inc. | 3,388,249 | $60,582 | 74.3% | $5.53 | — | COM | 773122106 |
| RXRX | Recursion Pharmaceuticals, Inc. | 3,951,141 | $20,902 | 25.7% | $18.82 | -61.3% | CL A | 75629V104 |